NeuroCycle Therapeutics to Research Next-Generation Treatment of Dravet Syndrome at UWM
This month research scientists from NeuroCycle Therapeutics, Inc. (NCT) will begin research on a potential next generation treatment of Dravet Syndrome in labs located within the Milwaukee Institute for Drug Discovery, which is directed by Dr. Stafford. Dravet Syndrome (DS)… Read More